Tag: Phase I Trial
Alladapt Enrolling Participants for Clinical Study of OIT Therapy to Treat...
The study is still seeking participants 4-55 years of age.
Aquestive Charts Ambitious Path Forward for Sublingual Emergency Epinephrine
Company updates the public on status of their candidate drug administered under the tongue.
Emergency Epinephrine Film Begins Phase 1 Clinical Trials
First healthy volunteer dosed in a Phase 1 study of AQST-108 for the treatment of allergic reactions including anaphylaxis.
Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...
Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and current asthma.
Phase I Trial for New Peanut Allergy Immunotherapy Results in No...
Research details phase one study of peptide-based immunotherapy, which is designed to remove risks of acute reactions during treatment.
Can Fecal Transplant Cure Peanut Allergy? Phase I Trial Underway
Can transplanting the microbiota of a healthy person to that of an allergic individual prevent allergic reactions?
Phase I Trial of Epinephrine Nasal Spray for Anaphylaxis Begins
Could lead the way to approval of a less anxiety provoking method of epinephrine administration.
Novel Peanut Allergy Vaccine Begins Phase I Clinical Trials
Vaccine uses peptides selected from parts of the peanut protein that do not cause life-threatening anaphylactic reactions.
Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II
The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.
